Clinical Experience on 225Ac-PSMA-617 Targeted Alpha Therapy in Metastatic Castration Resistant Prostate Cancer Patients: Safety and Efficacy Results

被引:0
|
作者
Yadav, Madhav [1 ]
Ballal, Sanjana [1 ]
Bal, Chandrasekhar [1 ]
Tripathi, Madhavi [1 ]
机构
[1] All India Inst Med Sci, Nucl Med, New Delhi, India
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
589
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Clinical Experience on 225Ac-PSMA-617 Targeted Alpha Therapy in Metastatic Castration Resistant Prostate Cancer Patients: Safety and Efficacy Results
    Bal, Chandrasekhar
    Yadav, Madhav
    Ballal, Sanjana
    Tripathi, Madhavi
    Sahoo, Ranjit
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [2] Efficacy and safety of 225Ac-PSMA-617 targeted alpha therapy in metastatic castration-resistant Prostate Cancer patients
    Yadav, Madhav Prasad
    Ballal, Sanjana
    Sahoo, Ranjit Kumar
    Tripathi, Madhavi
    Seth, Amlesh
    Bal, Chandrasekhar
    THERANOSTICS, 2020, 10 (20): : 9364 - 9377
  • [3] Efficacy and Safety of 225Ac-PSMA-617 Targeted Alpha Therapy in Metastatic Castration-Resistant Prostate Cancer Patients
    Yadav, M.
    Ballal, S.
    Bal, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S420 - S420
  • [4] 225Ac-PSMA-617 Targeted Alpha Therapy in Metastatic Castration Resistant Prostate Cancer Patients
    Yadav, Madhav
    Ballal, Sanjana
    Tripathi, Madhavi
    Bal, Chandrasekhar
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [5] The efficacy and safety of 225Ac-PSMA-617 in metastatic castration-resistant prostate cancer
    Ma, Jiao
    Zhang, Yu
    Yangqing, Jiangchu
    Liu, Guangfu
    Wang, Junzheng
    Zhang, Chunyin
    FRONTIERS IN ONCOLOGY, 2025, 15
  • [6] 225Ac-PSMA-617 targeted alpha therapy after Docetaxel based chemotherapy in the patients of metastatic castration resistant prostate cancer
    Sen, Ishita
    Pant, Vineet
    Thakral, Parul
    Raina, Vinod
    Das, Subha
    Sharma, Kanchan
    Manda, Divya
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [7] 225Ac-PSMA-617 for PSMA-Targeted a-Radiation Therapy of Metastatic Castration-Resistant Prostate Cancer
    Kratochwil, Clemens
    Bruchertseifer, Frank
    Giesel, Frederik L.
    Weis, Mirjam
    Verburg, Frederik A.
    Mottaghy, Felix
    Kopka, Klaus
    Apostolidis, Christos
    Haberkorn, Uwe
    Morgenstern, Alfred
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (12) : 1941 - 1944
  • [8] Survival outcomes of patients with metastatic castration resistant prostate cancer receiving 225Ac-PSMA-617 radioligand therapy
    Bal, Chandrasekhar
    Ballal, Sanjana
    Yadav, Madhav
    Sahoo, Ranjit
    Tripathi, Madhavi
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [9] 225Ac-PSMA-617/177Lu-PSMA-617 tandem therapy of metastatic castration-resistant prostate cancer: pilot experience
    Fadi Khreish
    Niklas Ebert
    Martin Ries
    Stephan Maus
    Florian Rosar
    Hendrik Bohnenberger
    Tobias Stemler
    Matthias Saar
    Mark Bartholomä
    Samer Ezziddin
    European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 : 721 - 728
  • [10] 225Ac-PSMA-617/177Lu-PSMA-617 tandem therapy of metastatic castration-resistant prostate cancer: pilot experience
    Khreish, Fadi
    Ebert, Niklas
    Ries, Martin
    Maus, Stephan
    Rosar, Florian
    Bohnenberger, Hendrik
    Stemler, Tobias
    Saar, Matthias
    Bartholomae, Mark
    Ezziddin, Samer
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (03) : 721 - 728